|
시장보고서
상품코드
2039126
나노의약품 시장 : 용도별, 지역별Nanomedicines Market, By Application (Cardiovascular, Anti-inflammatories, Anti-infectives, Neurology, Oncology, Others (dental, orthopedic, urology, ophthalmic)), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
나노의약품 시장은 2026년에 4,081억 달러로 추정되며, 2033년까지 9,255억 달러에 이를 것으로 예상되고 있습니다. 또한 2026-2033년 CAGR은 12.9%를 보일 전망입니다.
| 분석 범위 | 분석 상세 | ||
|---|---|---|---|
| 기준 연도 | 2025년 | 시장 규모(2026년) | 4,081억 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR | 12.90% | 예측 금액(2033년) | 9,255억 달러 |
나노의약품 제품은 약물전달, 생체영상, 체외진단, 재생의료, 치과, 의료기기, 피부용 등으로 활용되고 있습니다. 세계 나노의약품 시장의 주요 시장 성장 촉진요인으로는 정부의 지원 확대와 더불어 당뇨병, 비만, 암, 정형외과 질환, 신장질환 등 만성질환 발생률의 지속적인 증가를 꼽을 수 있습니다. 또한, 세계 나노 의약품 시장의 주요 기업들은 제품 포트폴리오를 확장하기 위해 신제품 연구 및 개발에 주력하고 있습니다.
본 보고서의 주요 특징
- 이 보고서는 각 부문의 잠재적 수익 기회를 밝히고 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한, 시장 촉진 및 억제요인 및 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 업체들의 경쟁 전략 등에 대한 중요한 고찰을 제공합니다.
- 세계 나노의학 시장의 주요 기업 프로파일을 다양한 매개변수(기업 개요, 제품 포트폴리오, 주요 특징, 재무 실적, 전략 등)에 따라 정리하여 전해드립니다.
- 이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형 업데이트, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
- '세계 나노 의약품 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 나노 의약품 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.
목차
제1장 분석 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 나노의약품 시장 : 용도별(2021년-2033년)
제5장 세계의 나노의약품 시장 : 지역별(2021년-2033년)
제6장 경쟁 구도
제7장 섹션
LSH 26.06.04Nanomedicines Market is estimated to be valued at USD 408.1 Bn in 2026 and is expected to reach USD 925.5 Bn by 2033, growing at a compound annual growth rate (CAGR) of 12.9% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 408.1 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 12.90% | 2033 Value Projection: | USD 925.5 Bn |
Nanomedicine products have applications in drug delivery, in vivo imaging, in vitro diagnostics, regenerative medicine, dental, medical devices, and dermal applications. Major drivers for the global nanomedicine market constitutes of increasing government support as well as continuous increase in the occurrence of chronic diseases including diabetes, obesity, cancer, orthopedic diseases, and kidney disorder. Furthermore, major players in the global nanomedicine market are focused on R&D of new products to expand their product portfolio.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
- It profiles key players in the Global Nanomedicines market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include, Abbott Laboratories, CombiMatrix Corporation, Clene Nanomedicine, Inc., Cellics Therapeutics, Inc., Nanobiotix S.A, Celgene Corporation, GE Healthcare, NanoViricides, Inc., Johnson & Johnson, Mallinckrodt plc., Sirnaomics Inc., Precision NanoSystems Inc., Merck & Company Inc., Nanosphere, Inc., Pfizer Inc., and Sigma-Tau Pharmaceuticals Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
- The Global Nanomedicines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Nanomedicines market
Market Segmentation
- By Application Insights (Revenue, USD Bn, 2021 - 2033)
- Cardiovascular
- Anti-inflammatories
- Anti-infective
- Neurology
- Oncology
- Others (dental, orthopedic, urology, opthalmic).
- By Region Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa
- GCC Countries
- Israel
- Rest of Middle East & Africa
- Key Players
- Abbott Laboratories
- CombiMatrix Corporation
- Clene Nanomedicine, Inc
- Cellics Therapeutics, Inc
- Nanobiotix S.A
- Celgene Corporation
- GE Healthcare
- NanoViricides, Inc
- Johnson & Johnson
- Mallinckrodt plc
- Sirnaomics Inc
- Precision NanoSystems Inc
- Merck & Company Inc
- Nanosphere, Inc
- Pfizer Inc
- Sigma-Tau Pharmaceuticals Inc
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Application
- Market Snippet, By Country
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Key Highlights
- Product launch
- PEST Analysis
- Technological Advancements
- Regulatory Scenario
- Mergers and Acquisitions
4. Global Nanomedicines Market, By Application, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Cardiovascular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Anti-inflammatories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Anti-infective
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others (dental, orthopedic, urology, opthalmic)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Global Nanomedicines Market, By Region, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2021-2033
- North America
- Market Size and Forecast, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
- Germany
- U.K.
- France
- Spain
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
- China
- Japan
- India
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Market Size and Forecast, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
- North Africa
- Central Africa
- South Africa
6. Competitive Landscape
- Company Profiles
- Abbott Laboratories
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- CombiMatrix Corporation
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Clene Nanomedicine, Inc
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Cellics Therapeutics Inc
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Nanobiotix S.A
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Celgene Corporation
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- GE Healthcare
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- NanoViricides, Inc
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Johnson & Johnson
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Mallinckrodt plc
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Sirnaomics Inc
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Precision NanoSystems Inc
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Merck & Company Inc
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Nanosphere, Inc
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Pfizer Inc
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Sigma-Tau Pharmaceuticals Inc
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Abbott Laboratories
7. Section
- References
- Research Methodology
- About us and Sales Contact
